These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 32585913)

  • 1. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.
    Elshabrawy HA
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside Inhibitors of Coronaviruses.
    Zenchenko AA; Drenichev MS; Mikhailov SN
    Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.
    Tse LV; Meganck RM; Graham RL; Baric RS
    Front Microbiol; 2020; 11():658. PubMed ID: 32390971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
    Ashour HM; Elkhatib WF; Rahman MM; Elshabrawy HA
    Pathogens; 2020 Mar; 9(3):. PubMed ID: 32143502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.
    Raoult D; Zumla A; Locatelli F; Ippolito G; Kroemer G
    Cell Stress; 2020 Mar; 4(4):66-75. PubMed ID: 32292881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of COVID-19, SARS and MERS.
    Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
    PeerJ; 2020; 8():e9725. PubMed ID: 32879801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.
    Bolinger AA; Li J; Xie X; Li H; Zhou J
    Expert Opin Drug Discov; 2024 Sep; 19(9):1023-1041. PubMed ID: 39078037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global emergence of severe acute respiratory syndrome coronavirus 2 in human.
    Mandal B
    Virusdisease; 2020 Jun; 31(2):67-70. PubMed ID: 32656303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New Generation
    Calistri A; Luganini A; Mognetti B; Elder E; Sibille G; Conciatori V; Del Vecchio C; Sainas S; Boschi D; Montserrat N; Mirazimi A; Lolli ML; Gribaudo G; Parolin C
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
    Sohrab SS; Suhail M; Kamal MA; Azhar EI
    Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin.
    Plante KS; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Sastry KJ; Newman RA; Weaver SC
    bioRxiv; 2020 Jul; ():. PubMed ID: 32699848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Prediction and Designing of Potential siRNAs to be used as Antivirals Against SARS-CoV-2.
    Sohrab SS; El-Kafrawy SA; Abbas AT; Bajrai LH; Azhar EI
    Curr Pharm Des; 2021; 27(32):3490-3500. PubMed ID: 33430748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
    Santos IA; Grosche VR; Bergamini FRG; Sabino-Silva R; Jardim ACG
    Front Microbiol; 2020; 11():1818. PubMed ID: 32903349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives.
    Koma T; Adachi S; Doi N; Adachi A; Nomaguchi M
    Front Microbiol; 2020; 11():2016. PubMed ID: 32983025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives.
    Gupta A; Kumar S; Kumar R; Choudhary AK; Kumari K; Singh P; Kumar V
    ChemistrySelect; 2020 Jul; 5(25):7521-7533. PubMed ID: 32835089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocides and Novel Antimicrobial Agents for the Mitigation of Coronaviruses.
    Dev Kumar G; Mishra A; Dunn L; Townsend A; Oguadinma IC; Bright KR; Gerba CP
    Front Microbiol; 2020; 11():1351. PubMed ID: 32655532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.